Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment

por Cheng, Bisheng, Huang, Hai
Publicado 2023

The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis

por Cheng, Bisheng, Ye, Shuchao, Bai, Peiming
Publicado 2021

Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancer

por Peng, Shirong, Zhang, Xinyu, Huang, Hao, Cheng, Bisheng, Xiong, Zhi, Du, Tao, Wu, Jun, Huang, Hai
Publicado 2022

The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment

por Cheng, Bisheng, Li, Lingfeng, Wu, Yongxin, Luo, Tianlong, Tang, Chen, Wang, Qiong, Zhou, Qianghua, Wu, Jilin, Lai, Yiming, Zhu, Dingjun, Du, Tao, Huang, Hai
Publicado 2023

ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression

por Li, Ni, Liu, Qiuli, Han, Ying, Pei, Siyu, Cheng, Bisheng, Xu, Junyu, Miao, Xiang, Pan, Qiang, Wang, Hanling, Guo, Jiacheng, Wang, Xuege, Zhang, Guoying, Lian, Yannan, Zhang, Wei, Zang, Yi, Tan, Minjia, Li, Qintong, Wang, Xiaoming, Xiao, Yichuan, Hu, Guohong, Jiang, Jun, Huang, Hai, Qin, Jun
Publicado 2022